IP Library Granted Patent US 8,380,312
Granted Patent B2
US 8,380,312 · App. 12/982,657 · Granted Feb 19, 2013

Multi-zone stimulation implant system and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,380,312
App. No.
12/982,657
Granted
Feb 19, 2013
Kind
B2
Abstract

Various embodiments of an implant system are provided. The implant, such as a mesh implant, can include a support structure, e.g., mesh sling or implant, one or more stimulation elements (e.g., leads), and an energizing element. Leads or electrodes can be positioned in desired stimulation zones of the implant. As such, the implant can include multiple electrically isolated mesh electrode pads or regions.

Claims (19)

1. An implant stimulation system for stimulating tissue of a pelvic region, said system comprising:

a formable support structure having a plurality of stimulation zones capable of independently stimulating different areas of a pelvic region, the support structure comprising frame portions separating the stimulation zones that is formable to the tissue being stimulated, the stimulation zones comprising mesh portions connected to the frame portions;

at least one lead being in operative communication with each stimulation zone; and

a control module in operative communication with the at least one lead to control the stimulus to each of the stimulation zones.

2. The stimulation system of claim 1 , further comprising a remote control in operative communication with the control module to allow a user or physician to control the stimulus to the stimulation zones.

3. The stimulation system of claim 1 , wherein the mesh portion comprises a conductive material to spread the stimulus over the area of the stimulation zone.

4. The stimulation system of claim 1 , wherein the mesh portion comprises pores having a uniform opening across the stimulation zones.

5. The stimulation system of claim 1 , wherein the mesh portion comprises pores having a non uniform opening across the stimulation zones.

6. The stimulation system of claim 1 , wherein the stimulation zones are simultaneously stimulated.

7. The stimulation system of claim 1 , wherein the stimulation zones are selectively stimulated by a user or physician.

8. The stimulation system of claim 1 , further comprising at least one fixation device being coupled to at least one of the leads to prevent movement of the lead in a patient.

9. The stimulation system of claim 8 , wherein the fixation device comprises one or more tines extending angularly away from the lead.

10. The stimulation system of claim 8 , further comprising a capsule encasing at least one fixation device in a collapsed state.

11. The stimulation system of claim 10 , wherein the capsule is dissolvable to permit the fixation device to move from a collapsed state to an expanded state.

12. An implant stimulation system for stimulating tissue of a pelvic region, said system comprising:

at least one lead being in operative communication with an organ or tissue of a pelvic region;

a helical anchor disposed on a tip of the lead;

a dissolvable capsule encasing the helical anchor and retaining the helical anchor in a compressed state and allowing the helical anchor to expand to an expanded state upon dissolving; and

a control module in operative communication with the at least one lead to control the stimulus thereto.

Assignments (13)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043780/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043778/0302 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA; PREVIOUSLY RECORDED ON REEL 037300 FRAME 0199. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Feb 25, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037916/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0745 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0919 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0199 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2011
From: GINDELE, PAUL J.
To: AMS RESEARCH CORPORATION
Reel/Frame 025731/0563 →